← Browse by Condition
Medical Condition

primary sj gren syndrome

Total Trials
2
Recruiting Now
2
Trial Phases
EARLY_Phase 1

ClinicalMetric tracks all active clinical trials for primary sj gren syndrome sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — primary sj gren syndrome Clinical Trials

How many clinical trials are currently recruiting for primary sj gren syndrome?
ClinicalMetric currently tracks 2 actively recruiting clinical trials for primary sj gren syndrome, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 2. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for primary sj gren syndrome?
primary sj gren syndrome research spans Phase 1 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a primary sj gren syndrome clinical trial?
Eligibility criteria for primary sj gren syndrome trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Top Sponsors
Changhai Hospital 1 trial
Peking Union Medical College Hospital 1 trial

Recruiting Clinical Trials

NCT07246096 EARLY_Phase 1
Recruiting
Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases
Enrollment
60 pts
Location
China
Sponsor
Changhai Hospital
View Trial →
NCT07324733
Recruiting
Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Imaging
Enrollment
60 pts
Location
China
Sponsor
Peking Union Medical College H...
View Trial →

Related Conditions

autoimmune diseases (1) systemic lupus erythematosus (1) systemic sclerosis (1) rheumatoid arthritis (1) anti neutrophil cytoplasmic antibody associated vasculitis (1) pet (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology